| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $21.0M | -51.8% | +96.1% |
| R&D Expense | $54.4M | -11.8% | -6.6% |
| SG&A Expense | $14.2M | -6.4% | -4.2% |
| Operating Income | -$47.5M | -43.3% | +23.7% |
| Pre-tax Income | -$6.0M | +80.6% | +87.0% |
| Income Tax | $0 | +100.0% | — |
| Net Income | -$6.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $28.3M | -36.3% | -2.5% |
| Accounts Receivable | $21.8M | -54.1% | +113.7% |
| Current Assets | $518.4M | +1.0% | -9.6% |
| Total Assets | $868.8M | -1.2% | -11.7% |
| Current Liabilities | $86.5M | -10.0% | -6.0% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$83.4M | — | — |
| Capital Expenditures | $2.0M | — | — |
| Investing Cash Flow | $68.8M | — | — |
| Financing Cash Flow | $1.9M | — | — |
| Free Cash Flow | -$85.4M | — | — |
| +86.6% |
| EPS (Basic) | -$0.08 | +80.5% | +88.7% |
| EPS (Diluted) | -$0.08 | +80.5% | +88.7% |
| $87.8M |
| -7.3% |
| +763.2% |
| Total Liabilities | $243.5M | -6.0% | -7.3% |
| Stockholders' Equity | $625.3M | +0.8% | -13.6% |